The largest holder of Zimmer Biomet stock is Dodge & Cox, with 24.1 million shares (12.47% of the company), worth about $2.41 billion as of September 25, 2026. The 10 largest holders together own 54.5%.
In Q2 2026, 944 institutional holdings reports listed shares worth $17.40 billion.
Insiders reported 61 transactions in the last two years: 8 sales worth $1.10 million and no purchases. The newest one on file is from April 1, 2026 (Noor Jehanzeb, Officer).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through April 1, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Dodge & Cox | 24.1 million | 12.47% | $2.4B |
| Harris Associates LP | 12.7 million | 6.58% | $1.3B |
| Vanguard Capital Management LLC | 12.6 million | 6.53% | $1.3B |
| BlackRock Advisors LLC | 12.3 million | 6.35% | $1.2B |
| Capital Research & Management Co. (International Investors) | 12.2 million | 6.30% | $1.2B |
| State Street Corporation | 8.9 million | 4.59% | $888.0M |
| Vanguard Portfolio Management LLC | 8.4 million | 4.36% | $845.0M |
| Geode Capital Management LLC | 5.3 million | 2.77% | $535.0M |
| T. Rowe Price International Ltd. | 4.8 million | 2.48% | $480.0M |
| Invesco Advisers, Inc. | 4.0 million | 2.06% | $398.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 944 | – | $17.4B |
| Q1 2026 | 942 | 192.0 million | $17.4B |
| Q4 2025 | 980 | 199.0 million | $17.9B |
| Q3 2025 | 1,007 | 193.0 million | $19.0B |
| Q2 2025 | 973 | 194.0 million | $17.7B |
| Q1 2025 | 1,042 | 185.0 million | $21.0B |
| Q4 2024 | 1,080 | 183.0 million | $19.3B |
| Q3 2024 | 1,031 | 185.0 million | $19.9B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Noor Jehanzeb | Apr 1, 2026 | Officer | -- | – |
| Winkler Lori | Mar 12, 2026 | Officer | Sale at price 94.66 per share. | $250,849 |
| Winkler Lori | Mar 6, 2026 | Officer | -- | – |
| Van Zuilen Wilfred | Mar 6, 2026 | Officer | -- | – |
| Yi Sang | Mar 6, 2026 | Officer | -- | – |
| Stellato Paul A | Mar 6, 2026 | Officer | -- | – |
| Tornos Ivan | Mar 6, 2026 | Chief Executive Officer | -- | – |
| Upadhyay Suketu P | Mar 6, 2026 | Chief Financial Officer | -- | – |
| Phipps Chad F | Mar 6, 2026 | Officer | -- | – |
| Winkler Lori | Feb 25, 2026 | Officer | -- | – |
| Van Zuilen Wilfred | Feb 25, 2026 | Officer | -- | – |
| Yi Sang | Feb 25, 2026 | Officer | -- | – |
Newest 12 of 61 insider transactions in the last two years.
Dodge & Cox, with 12.47% of the company (as of September 25, 2026). Next: Harris Associates LP (6.58%) and Vanguard Capital Management LLC (6.53%).
944 institutional holdings reports listed Zimmer Biomet shares in Q2 2026 worth $17.40 billion.
In the last two years insiders reported 8 sales and no purchases (61 transactions in all); the newest on file is from April 1, 2026.